Imatinib-induced Stevens-Johnsons syndrome

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Jha, Praveen ^a   Himanshu, D ^b   Jain, Nirdesh ^b   Singh, Ajay Kumar ^b  

^a Department of Internal Medicine   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BCR ABL PROTEIN; CALAMINE; DASATINIB; IMATINIB;

ADULT; ALLERGIC REACTION; ARTICLE; BONE MARROW EXAMINATION; BULLOUS SKIN DISEASE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FOLLOW UP; HUMAN; HUMAN TISSUE; LOTION; MALE; PRIORITY JOURNAL; RETREATMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

EID: 84874491183     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007926     Document Type: Article

References (12)

1. Valeyrie L, Bastuji-Garin S, Revuz J, et al. Adverse reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients. J Am Acad Dermatol 2003;48:201-6.
2. Ena P, Chiarolini F, Siddi GM, et al. Oral lichenoid eruption secondary to imatinib (Glivec). Dermatolog Treat 2004;15:253-5.
3. Hamm M, Touraud JP, Mannone L, et al. Imatinib-induced purpuric vasculitis. Ann Dermatol Venereol 2003;130:765-7.
4. Schaich M, Schakel K, Illmer T, et al. Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation. Ann Hematol 2003;82:303-4.
5. Tsao AS, Kantarjian H, Cortes J, et al. Imatinib mesylate causes hypopigmentation in the skin. Cancer 2003;98:2483-7.
6. Drummond A, Micallef-Eynaud P, Douglas WS, et al. A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec). Br J Haematol 2003;120:911-13.
7. Banka N, Aljurf M, Hamadah I. Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign. Dermatology 2003;207:329-30.
8. Sanchez-Gonzalez B, Pascual-Ramirez JC, Fernandez-Abellan P, et al. Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukaemia. Blood 2003;101:2446.
9. Hsiao LT, Chung HM, Lin JT, et al. Stevens-Johnson syndrome after treatment with STI571: A case report. Br J Haematol 2002;117:620-2.
10. Rule SA, O'Brien SG, Crossman LC. Managing cutaneous reactions to imatinib therapy. Blood 2002;100:3434-5.
11. Vidal D, Puig L, Sureda A, et al. STI571-induced Stevens-Johnson syndrome. Br J Haematol 2002;119:274-5.
12. Brouard M, Saurat JH. Cutaneous reactions to STI571. N Engl J Med 2001;345:618-19.